Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and plasma thrombomodulin levels in glioblastoma patients

Cancer Letters

Volumn 146, Issue 2, 1999, Pages 169-172

  Salmaggi, A ^a   Eoli, M ^a   Frigerio, S ^a   Ciusani, E ^a   Silvani, A ^a   Boiardi, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Adhesion molecules: Thrombomodulin; Glioblastoma

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; THROMBOMODULIN; TUMOR MARKER; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

FEMALE; GLIOBLASTOMA; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032745580     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00255-4     Document Type: Article

References (21)

1. Nasu K., Narahara H., Etoh Y., Kawano Y., Hirota Y., Miyakawa I. Serum level of soluble intercellular adhesion molecule-1 and the expression of ICAM-1 mRNA in uterine cervical cancer. Gynecol. Oncol. 65:(2):1997;304-308.
2. Tsujisaki M., Iami K., Hirata H., Hanzawa Y., Masuya J., Nakano T., Tsugigama T., Matsui M., Hinoda Y., Yachi A. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin. Exp. Immunol. 85:1991;3-8.
3. Harning R., Mainolfi E., Bystryn J.C., Henn M., Merluzzi V.J., Rothlein R. Serum levels of circulating intercellular adhesion molecule-1 in human malignant melanoma. Cancer Res. 51:1991;5003-5005.
4. Banks R.E., Gearing A.J.H., Hemingway I.K., Norfolk D.R., Perren T.J., Selby P.J. Circulating intercellular adhesion molecule-1. E selectin and vascular cell adhesion molecule-1 (VCAM) in human malignancies. Br. J. Cancer. 68:1993;122-124.
5. Kuppner M.C., Van Meier E., Hamou M.F., de Tribolet N. Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells. Clin. Exp. Immunol. 81:1990;142-148.
6. Rice G.E., Bevilacqua M.P. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science. 246:1989;1303-1306.
7. Couldwell W.T., de Tribolet N., Antel J.P., Gautier T., Kuppner M.C. Adhesion molecules and malignat gliomas: implications for tumorigenesis. J. Neurosurg. 76:1992;782-791.
8. Esmon C.T. The role of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264:1989;4743-4746.
9. Dittman W.A., Majerous P.W. Structure and function of thrombomodulin: a natural anticoagulant. Blood. 75:1990;329-336.
10. Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb. Haemost. 65:1991;618-623.
11. Boffa M.C., Karmochine M., Berard M. Plasma thrombomodulin as a marker for endothelium damage. Nouv. Rev. Fr. Haematol. 33:1991;529-530.
12. Chen T.C., Hinton D.R., Sippy B.D., Hofman F.M. Soluble TNF alpha receptor are constitutively shed and downregulate adhesion molecule expression in malignant gliomas. J. Neuropathol. Exp. Neurol. 56:1997;541-550.
13. Doukas J., Pober J.S. IFN gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. J. Immunol. 145:1990;1727-1733.
14. Valent P., Bevec D., Maurer D., Besemer J., DiPadova F., Butterfield J.H., Spelser W., Majdie O., Lechner K., Bettelheim P. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc. Natl. Acad. Sci. USA. 88:1991;3339-3342.
15. Takano S., Kimura S., Ohdama S., Aoki N. Plasma thrombomodulin in health and disease. Blood. 76:1990;2024-2029.
16. Iwashima Y., Sato T., Watanabic K., Osohima E., Hiraishi S., Ishii H., Kazama M., Makino I. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes. 59:1990;983-988.
17. Takahashi H., Hanano M., Wada K., Tatcwaki W., Niwano H., Tsubouchi J., Nakano M., Nakamura T., Shibata A. Circulation thrombomodulin in thrombotic throbocytopenia purpura. Am. J. Hematol. 38:1991;174-177.
18. Lindahl A.K., Boffa M.C., Abilgaard U. Increased plasma thrombomodulin in cancer patients. Thromb. Haemost. 9:1993;112-114.
19. Bajaj M.S., Kuppusswami M.N., Saito H., Spitzer S.G., Bajaj S.P. Cultured normal hepatocytes do not synthesize lipoprotein associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc. Natl. Acad. Sci. USA. 87:1990;8869-8873.
20. Ishii H., Salem H.H., Bell C.E., Laposata E.A., Majerus P.W. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. Blood. 67:1986;362-365.
21. Isaka T., Yoshimine T., Maruno M., Hayakawa T. Alterd expression of antithrombotic molecules in human glioma vessels. Acta Neuropathol. 87:1994;81-85.